|
APVO Aptevo Therapeutics Inc 1671584 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-6,356,000.00 |
| Balance Sheet |
|
Current Assets
|
$10,798,000.00 |
|
Assets
|
$14,519,000.00 |
|
Current Liabilities
|
$5,188,000.00 |
|
Liabilities
|
$8,478,000.00 |
|
Equity
|
$6,041,000.00 |
|
Shares Out
|
1418952.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-13,419,000.00 |
| Market Analysis |
Market Cap
|
$3,916,307.52 |
|
Price
|
$2.76 |
|
BVPS
|
4.26 |
|
PB
|
0.65 |
|
EPS
|
-5.31 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:02 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:52 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view APVO documents filed with the SEC.
APVO Filings
Clear
